A triple therapy for glioblastoma, consisting of two types of immunotherapy and targeted radiation, has significantly prolonged the survival of mice with these brain cancers, according to a new report.
Healthy men participating in the Prostate Cancer Prevention Trial who actively participate in all trial steps are most likely to undergo a biopsy at the end of the trial, according to recent research.
A drug originally used to treat ovarian cancer has shown promising results in patients with advanced peritoneal cancers during a phase I clinical trial.
Scientists have known for decades that cancer can be caused by genetic mutations, but more recently they have discovered that chemical modifications of a gene can also contribute to cancer.
By analyzing the DNA sequence of patients at different stages of leukemia, researchers have discovered mutations in genes that lead to childhood leukemia of the acute lymphoblastic type, the most common childhood cancer.
AHA supports inclusion of e-cigarettes in state and federal laws prohibiting sale and marketing to minors.
Increased risk of subsequent colorectal cancer (CRC) in first year of diagnosis may be a screening effect, according to research.
Needle-guided tumor destruction procedures offer near equivalent lengths of cancer control when compared with surgery for patients with small kidney cancer tumors.
Researchers have identified a gene that contributes to the development of several childhood cancers, research that could lead to new strategies for targeting certain childhood cancers at a molecular level.
Screening with flexible sigmoidoscopy resulted in a reduced incidence and rate of death of colorectal cancer, compared with no screening, according to a recent study.
Adoptive T-cell therapy, a type of immunotherapy, appears to recognize unique cancer mutations that stimulate immune responses.
A new lung screening service for persons at high risk for lung cancer with incorporates a same-day visit by a nurse practitioner after the patient undergoes low-dose CT to discuss test results and recommendations.
Although nurses are familiar with palliative care guidelines related to cancer anorexia-cachexia syndrome, a needs-assessment survey revealed they are less familiar with novel therapeutic interventions in development.
Burnout was reduced and secondary trauma improved by a 6-week initiative to prevent compassion fatigue.
Pre- and postimplementation surveys are effective tools to confirm staff understanding of and adherence to a new neurologic assessment process for patients receiving high-dose cytarabine.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|